The COVID-19 pandemic continues to evolve and impact our personal and professional lives. We want to assure our trustees, reviewers, and grantee communities that our TMF staff continues to provide high quality biomedical research grantmaking services. We will do our part to help manage any potential challenges and continue supporting research to the extent that it is possible. Please notify us with any questions or requests.
PROMOTING HUMAN DISEASE RESEARCH BY EARLY-CAREER CLINICAL INVESTIGATORS
The Robert E. Leet and Clara Guthrie Patterson Trust, Bank of America, N.A., Trustee, was created in 1980 for the advancement of medical science, particularly research “relating to human diseases, their causes and relief.” Two-year Awards of $90,000 ($45,000 per year) will be awarded to Applicants working in Connecticut, New Jersey and Rhode Island.
The primary goal of the Program is to support research that focuses on the causes of human disease and/or improving treatment. To achieve this goal the Patterson Trust supports mentored clinical investigators in the early stages of their research careers to promote the pursuit of academic research careers as successful independent investigators. The Program supports innovative research and pilot studies spanning a broad range of disciplines including both patient-oriented clinical research and translational laboratory research.
Any cancer-related proposals submitted for consideration for the Patterson Trust Award will also be eligible to be considered for the Seery Foundation Clinical Investigator Award.
The William O. Seery Foundation, established in 2010 to “support research for the treatment and cure of cancer of all types,” will consider cancer-related proposals submitted through the Patterson application process for funding for a Seery award.